文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

泪液血管生成因子:早产儿视网膜病变筛查的潜在无创生物标志物

Tear Fluid Angiogenic Factors: Potential Noninvasive Biomarkers for Retinopathy of Prematurity Screening in Preterm Infants.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2021-01-01

该前瞻性研究纳入36例接受常规ROP筛查的早产儿,按有无ROP及病变变化分组,用Schirmer试纸采集泪液并以多重ELISA检测促血管生成因子。首次访视时ROP组VEGF较低、angiogenin较高,angiogenin与出生体重、胎龄及VEGF的比值可区分有无ROP。

要点

  • 首次访视ROP组泪液VEGF低于无ROP组,angiogenin高于无ROP组。
  • angiogenin与出生体重、胎龄及VEGF的比值有潜力作为ROP无创筛查标志物。
  • ROP进展组首次访视VEGF和angiogenin水平显著更低。

核心结论

  • angiogenin与ROP相关,提示其可能参与ROP。
  • angiogenin与出生体重、胎龄和/或VEGF的比值可作为ROP潜在无创筛查生物标志物。

研究设计与样本

  • 前瞻性研究纳入36例接受常规ROP筛查的早产儿。
  • 分为无ROP组13例、ROP组18例、无ROP转为ROP组5例。
  • ROP组按首次与后续访视间病变演变分为进展组7例和消退组16例。
  • 用Schirmer试纸采集泪液,以多重ELISA检测VEGF、angiogenin、可溶性血管细胞黏附分子和fractalkine水平(皮克/毫升)。

主要发现

  • 首次访视ROP组VEGF为135±69,低于无ROP组的172.5±54.0。
  • 首次访视ROP组angiogenin为6568±4975,高于无ROP组的4139±3909。
  • 无ROP转为ROP组VEGF显著低于无ROP组和ROP组。
  • ROP进展组首次访视VEGF和angiogenin水平显著低于消退组。
  • ROP组angiogenin水平与出生体重和胎龄呈负相关。

关键数值与推荐

  • angiogenin/出生体重比值:AUC=0.776,OR=8.6。
  • angiogenin/胎龄比值:AUC=0.706,OR=7.3。
  • angiogenin/VEGF比值:AUC=0.806,OR=14.3。
  • 上述比值可区分有无ROP的早产儿。

临床怎么用

  • 泪液angiogenin及其与出生体重、胎龄、VEGF的比值可能用于ROP无创筛查。
  • 进展性ROP患儿首次访视泪液VEGF和angiogenin水平更低,或可辅助识别进展风险。

局限性

  • 样本量较小(共36例,进展组仅7例)。
  • 单中心前瞻性研究,结果需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the status of proangiogenic factors in the tear fluid of preterm infants with and without retinopathy of prematurity (ROP). METHODS: Preterm infants (n = 36) undergoing routine ROP screening included in the prospective study were categorized as No-ROP (n = 13, no ROP at any visits), ROP (if ROP was present at first visit; n = 18), or No-ROP to ROP (no disease at first visit, but developed ROP subsequently; n = 5). Infants with ROP were also grouped as progressing (n = 7) and regressing (n = 16) based on ROP evolution between the first and subsequent visits. Schirmer's strips were used to collect tear fluid and proangiogenic factors (VEGF, angiogenin, soluble vascular cell adhesion molecule, and fractalkine) levels (in picograms per milliliter) in tear fluid were measured by multiplex ELISA. RESULTS: Lower levels of VEGF (135 ± 69; mean ± standard deviation) and higher levels of angiogenin (6568 ± 4975) were observed in infants with ROP compared with infants without ROP (172.5 ± 54.0; 4139 ± 3909) at the first visit. Significantly lower levels of VEGF were observed in the No-ROP to ROP group compared with the No-ROP and ROP groups. The VEGF and angiogenin levels at the first visit were significantly lower in infants with ROP with progressing disease. Angiogenin levels negatively correlated with birth weight and gestational age in ROP. The area under the curve (AUC) and odds ratio (OR) analysis demonstrated that angiogenin/birth weight (AUC = 0.776; OR, 8.6); angiogenin/gestational age (AUC = 0.706; OR, 7.3) and Angiogenin/VEGF (AUC = 0.806; OR, 14.3) ratios were able to differentiated preterm infants with and without ROP. CONCLUSIONS: The association between angiogenin and ROP suggests its possible role in ROP. The ratio of angiogenin level with birth weight, gestational age, and/or VEGF could serve as a potential noninvasive screening biomarker for ROP.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Vinekar A, Nair AP, Sinha S, et al. Tear Fluid Angiogenic Factors: Potential Noninvasive Biomarkers for Retinopathy of Prematurity Screening in Preterm Infants. Invest Ophthalmol Vis Sci. 2021. PMID: 33646290. doi:10.1167/iovs.62.3.2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。